Top Buy
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | 38 | 0 | 20 | 0 | €96.15 | €109.09 | 13.463% |
| AbbVie Inc. | 48 | 0 | 26 | 0 | €159.20 | €176.57 | 10.909% |
| Abeona Therapeutics Inc. | 8 | 1 | 4 | 0 | €4.90 | €13.92 | 184.051% |
| Acadia Pharmaceuticals | 29 | 1 | 3 | 0 | €17.08 | €31.28 | 83.196% |
| Achieve Life Sciences Inc. | 11 | 1 | 11 | 1 | €4.46 | €6.50 | 45.903% |
| AC Immune Ltd | 6 | 0 | 2 | 0 | €3.47 | €8.68 | 150.006% |
| Aclaris Therapeutics Inc | 19 | 0 | 18 | 0 | €1.27 | €2.50 | 97.472% |
| Actinium Pharmaceuticals Inc. | 21 | 0 | 19 | 0 | €6.71 | €8.50 | 26.677% |
| Actinogen Ltd | 12 | 0 | 12 | 0 | €0.046 | €0.060 | 31.868% |
| Adaptimmune Therapeutics PLC ADR | 3 | 0 | 3 | 0 | €1.13 | €2.00 | 76.991% |
| Adverum Biotechnologies Inc. | 9 | 0 | 2 | 0 | €1.38 | €5.60 | 305.913% |
| Affimed N.V. | 12 | 6 | 0 | 0 | €0.55 | €6.61 | 1095.570% |
| Agios Pharmaceuticals Inc. | 8 | 1 | 1 | 1 | €44.20 | €48.75 | 10.293% |
| Akebia Therapeutics Inc. | 9 | 11 | 2 | 9 | €1.24 | €0.98 | -20.648% |
| Akero Therapeutics Inc | 18 | 0 | 1 | 0 | €24.64 | €38.62 | 56.750% |
| Aldeyra Therapeutics Inc. | 20 | 1 | 18 | 1 | €3.80 | €5.50 | 44.813% |
| Alnylam Pharmace. | 47 | 0 | 11 | 0 | €220.50 | €251.80 | 14.196% |
| Amgen Inc. | 45 | 0 | 21 | 0 | €305.25 | €320.00 | 4.832% |
| Amicus Therapeutics Inc. | 7 | 0 | 0 | 0 | €9.65 | €17.64 | 82.774% |
| Amneal Pharmaceuticals Inc | 1 | 1 | 0 | 0 | €7.00 | €10.00 | 42.857% |
| AnaptysBio Inc | 8 | 1 | 0 | 0 | €31.60 | €45.21 | 43.070% |
| Anavex Life Sciences Corp | 11 | 2 | 11 | 0 | €5.17 | €6.50 | 25.677% |
| Angle plc | 12 | 0 | 12 | 0 | €0.17 | €0.25 | 48.810% |
| Anika Therapeutics | 5 | 0 | 0 | 0 | €25.20 | €28.29 | 12.265% |
| Ani Pharmaceuticals Inc. | 18 | 1 | 18 | 1 | €58.00 | €69.75 | 20.259% |